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Thomas Kuhn’s famous model of the components and dynamics of scientific revolutions
is still dominant to this day across science, philosophy, and history. The guiding
philosophical theme of this article is that, concerning actual revolutions in neuroscience
over the past 60 years, Kuhn’s account is wrong. There have been revolutions, and
new ones are brewing, but they do not turn on competing paradigms, anomalies, or
the like. Instead, they turn exclusively on the development of new experimental tools.
I adopt a metascientific approach and examine in detail the development of two recent
neuroscience revolutions: the impact of engineered genetically mutated mammals in
the search for causal mechanisms of “higher” cognitive functions; and the more recent
impact of optogenetics and designer receptors exclusively activated by designer drugs
(DREADDs). The two key metascientific concepts, I derive from these case studies are
a revolutionary new tool’s motivating problem, and its initial and second-phase hook
experiments. These concepts hardly exhaust a detailed metascience of tool development
experiments in neuroscience, but they get that project off to a useful start and distinguish
the subsequent account of neuroscience revolutions clearly from Kuhn’s famous model.
I close with a brief remark about the general importance of molecular biology for a current
philosophical understanding of science, as comparable to the place physics occupied
when Kuhn formulated his famous theory of scientific revolutions.
Keywords: Thomas Kuhn’s model of scientific revolution, tool development experiments, metascience, gene
targeting techniques, optogenetics and DREADDs, motivating problem, hook experiments
KUHN’S MODEL AND NEUROSCIENCE
Kuhn’s (1962) model of scientific revolution still pervades much discussion in science,
philosophy, and history. A dominant paradigm eventually emerges within a scientific field.
All practitioners learn it—its practices, models, exemplars, and most prominent applications.
Normal science ensues: these resources get developed further and the paradigm gets
extended beyond its initial applications. Yet anomalies start to arise—applications which
seem intuitively promising for the paradigm, but which prove recalcitrant to absorption.
Anomalies pile up, and some practitioners begin to notice patterns among them, which
suggest the outlines of a new paradigm. Conservative practitioners hold to the still-dominant
paradigm, and continue pursuing normal science; radicals, often younger scientists, flock
to the emerging new paradigm, to develop its components and extend its applications. At
this stage revolutionary science ensues, and evidence and rational argument are only two of
numerous coercive techniques employed. In successful revolutions the emerging new paradigm
wins out—often because the older defenders of the previously dominant paradigm retire or die.
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Its basic resources get fleshed out and extended, and a new period
of normal science ensues, now under the direction of the new
paradigm.
This narrative is familiar, easy to recite, and since Kuhn’s first
book has been applied almost algorithmically to numerous cases
from science’s history. Expectedly, it guides much thinking when
new scientific revolutions are heralded. Everybody knows what
to look for: components of the dominant paradigm, troublesome
anomalies, any patterns across them which suggest initial
sketches of the revolutionary paradigm, and the various extra-
rational persuasive techniques that characterize the revolutionary
stage.
In light of its continuing influence, this article’s principal
philosophical theme is that, concerning neuroscience over
the past 60 years, Kuhn’s model is wrong. There have been
revolutions in its fields, and new ones are brewing. But these
episodes do not adhere to Kuhn’s model. When it comes to one
of science’s hottest interdisciplinary endeavors, real revolutions
turn on a different dynamic. The failure of Kuhn’s model is also
not due to neuroscience’s languishing in some ‘‘pre-paradigm’’
phase. It is easy to cast current mainstream neuroscience in
Kuhnian terms. The basic resources are there.1 The problem is
deeper. Kuhn’s famous account misses the principal hinge.
My metascientific approach in this essay focuses on two
recent cases of neuroscientific revolution, both drawn from
cellular/molecular neurobiology, and behavioral neuroscience
using animal models. These are the fields I know best. However, I
will suggest revolutionary cases from other areas of neuroscience,
including one from cognitive neuroscience, which I suspect also
illustrate the metascientific points I will develop below.
REVOLUTIONS IN NEUROSCIENCE: THE
ROLE OF TOOL DEVELOPMENT
Silva et al. (2014) provide a recent foray into revolutionary
neuroscience. The authors derive a Framework of types of
experiments, and a set of procedures for integrating results
across experiments and labs, by analyzing landmark publications
from the field of molecular and cellular cognition (MCC). Using
rudimentary causal graph theory they then develop research
maps of published results, show how to derive causal maps
of pathways between neuroscientific phenomena from them,
and demonstrate the potential for automating these procedures.
Together these resources provide a huge aid for rational
1These resources include: a set of textbooks that govern education into
the discipline; a set of methods taught routinely to aspiring trainees, and
researchers learning new techniques; a set of agreed-upon experimental
results which inform new experiments (c.f. citation numbers for ‘‘classic’’
articles). What then explains the common impression, even among
neuroscientists that no ‘‘governing paradigm’’ exists? Probably this attitude is
due to the explicitly interdisciplinary scope of the field. Within given fields of
neuroscience-certainly within cellular/molecular/behavioral neurobiology-
many of Kuhn’s basic conditions on ‘‘paradigm’’ are evident; and I suspect
this is true for other fields in the discipline with which I am less familiar. It is
also worth noting in this content how vague Kuhn’s concept is Masterman’s
(1970) well-known critical notice of Kuhn (1962) counted 21 distinct
meanings in that work alone! I thank an anonymous reviewer for pushing me
to clarify my quick dismissal pf neuroscience’s still being ‘‘pre-paradigmatic.’’
experiment planning in current neuroscience, with the potential
‘‘to make scientific revolutionaries of us all’’ (Silva et al., 2014,
p. 177). Landreth and Silva (2013) provide useful solutions to
practical questions about implementing the program.
Like Silva et al. (2014) my goal in this article is to
answer a metascientific question. By ‘‘metascience’’ I mean
the attempt to understand scientific practice and products on
scientists’ terms, as unencumbered by philosophical assumptions
or presuppositions about what those practices or products
‘‘have to be or do’’ (Bickle, 2003, chapter 1; Bickle, 2008).
In short, I am asking questions about science, only here my
question is: what kick-starts actual neuroscience revolutions? Of
course, this question presupposes another. Which developments
constitute neuroscience revolutions—the real ‘‘game changers’’
in the discipline which set the stage for so much novel work that
followed? Consider four developments, from the past 60 years:
• single-cell recordings in vivo, and the subsequent assignments
of ‘‘field’’ properties (sensory, motor, memorial, etc.) to
individual neurons based upon their responses;
• manipulating individual protein components of intra- and
inter-cellular signaling pathways in genetically engineered
mammals (‘‘knock-outs’’, ‘‘transgenics’’), and measuring their
effects in vivo using well-established behavioral protocols;
• imaging increasingly smaller regions of the functioning human
brain; and
• most recently, using light stimuli to activate or inhibit
specific selected neurons in vivo, while the animal engages in
behavioral tasks.
Each of these developments was a bonafide revolution.
The first came to define reductionistic neuroscience from
the late 1950’s through the 1980’s. The second enabled
manipulation of hypothesized cellular and molecular causal
mechanisms with a precision that far outstripped the capacities
of stimulating electrodes and pharmacological interventions, and
has subsequently become part of the practices across virtually
all of behavioral neuroscience. The third now practically defines
the field of cognitive neuroscience.2 And I’ll have much to
say about the revolutionary nature of the fourth below. Each
of these revolutions stemmed directly from the development
and justification of a new experiment tool—at least one novel
to neuroscience at its time. The first revolution stemmed
from fine-tip, high-impedance conducting microelectrodes; the
second from the application of gene targeting techniques to
mammals; the third on positron-emission tomography (PET)
and less invasively, functional magnetic resonance imaging
(fMRI); and the fourth on technologies both for inducing
translation and synthesis of microbial opsin genes in mammalian
neurons and delivering the light stimulus to the manipulated
2There is a genuine dispute about whether cognitive neuroscience armed
with functional brain imaging methods is revolutionary. There is the well-
known ‘‘computational’’ approach in cognitive (neuro-) science, and the
many problems of consciousness. Perhaps the safest remark is that I am least
confident that the argument to be developed in this article correctly applies
to cognitive neuroscience. A serious investigating of this case is an important
project for future metascientific research. I thank an anonymous reviewer for
reminding me about these complexities.
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neurons. In short: understanding tool development is the key to
understanding real revolutions in actual neuroscience.
Silva et al. (2014) recognize tool development as one of
the three basic categories of experiments in MCC, at the most
abstract level of their Framework. But they then focus exclusively
on the nature of Connection experiments (a second of their three
basic categories), which seek evidence for hypothesized causal
relations between neuroscientific kinds, because Connection
experiments constitute the bulk of the published research in
MCC. The authors thus leave a metascientific treatment of Tool
Development experiments for future work. But note that their
entire Silva et al. (2014) book is an argument for developing a new
tool for revolutionizing experiment planning in neuroscience,
namely, research maps. Their approach is illuminating. When
neuroscientists self-consciously seek to revolutionize some aspect
of their discipline, their principal strategy is to develop a new tool.
CASE STUDY #1: GENE TARGETING IN
MAMMALIAN NEURONS
As a first step toward developing a metascience of revolutionary
tool development in neuroscience, I examine two detailed case
studies, both drawn from the four examples I noted above.
I will derive two concepts from investigating these cases:
motivating problem and hook experiments. Silva et al. (2014,
chapter 3) coined the term ‘‘hook experiment’’ to denote the first
experiments and publications which gained the field of MCC its
initial notice. I am building on that usage, although I will have
more to say about some specific features of hook experiments.
These two concepts hardly exhaust a metascientific analysis
of tool development in neuroscience, but they get an analysis
started—and distance the subsequent account of revolution in
neuroscience immediately from Kuhn’s model.
Consider first the application of gene targeting technology
into mammalian neuroscience.3 The basic outline of this case
study is relatively well known within neurobiology (although
some of the details I’ll stress often get ignored). This is an
important reason why I start a metasceintific analysis of tool
development with this case: an unfamiliar project is often best
illustrated initially by working with a well-known case. The
Benzer lab at Caltech had begun manipulating specific genes in
flies, and tracking their behavioral effects, as early as the late-
1960’s; by the late-1980’s they and other labs had developed over
20 specific learning and memory fly mutants (with expressive
names such as ‘‘rutabaga’’ and ‘‘dunce’’). Might it be possible to
extend such work to mammals, with their far richer behavioral
repertoires? This possibility seemed intuitively remote, due to
the myriad complexity between gene expression and protein
synthesis, and behavior in mammals (as compared to flies); but
was enhanced by the work of Capecchi at the University of Utah,
who first developed mammalian gene ‘‘knock-out’’ technologies
in the mid-1980’s. Thomas and Capecchi’s (1987) lab targeted
developmental genes in the mouse, but he asserted confidently
that the technique should be applicable to any cloned gene.
3See Silva et al. (2014, chapter 3) for additional details of this case study and
its aftermath, aimed at developing a metascience of Connection experiments.
This work eventually won Capecchi a share of the 2007 Nobel
Prize for Physiology or Medicine, shared with co-contributors
Martin Evans and Oliver Smithies. The press release for the
Prize heralded their work as ‘‘the beginning of a new era
in genetics’’ (http://www.nobelprize.org/nobel_prizes/medicine/
laureates/2007/press.html).
By the late 1980’s long-term potentiation (LTP), a form of
activity-dependent synaptic plasticity (enhancement), provided
a beguiling hypothesized neurobiological mechanism for
learning and memory. Originally discovered as a physiology
laboratory oddity in the 1960’s, the authors of its first systematic
experimental investigation speculated explicitly about its
potential role in memory (Bliss and Lømo, 1973). Much work,
both slice-physiological and behavioral in vivo, followed quickly.
The circumstantial case for the LTP → memory connection
was well known (Lynch, 1986). Then-recently discovered post-
synaptic N-methyl-D-aspartate receptors (NMDAR), activated
only during periods of strong membrane depolarization (to
remove a magnesium ion channel block), which permitted
calcium (Ca++) and sodium (Na=) influx when activated,
seemed ideally suited to be part of the mechanism for LTP
induction (although the experimentally confirmed molecular
details of NMDAR-dependent LTP were then quite sparse). Still,
many neuroscientists doubted that the LTP → learning and
memory causal connection had been established experimentally,
with a reasonable level of scientific confidence.
Morris’s (1989) systematic, multiple-experiment study using
D,L-2-amino-5-phosphonopentanoic acid (AP5; also known
as APV) was a big step forward. AP5 is a potent and
selective NMDAR antagonist, blocking the influx of Ca++
into the post-synaptic neuron. Morris (1989) administered
AP5 intraventricularly into rats prior to their performing
a variety of hippocampus- and non-hippocampus-dependent
learning and memory tasks (mostly water maze tasks, known
by Morris’s name). In rodent hippocampus slices, AP5 was
known to block LTP. Morris (1989) showed that it also decreased
memory performance in the hidden platform version of his
water maze task, but not the visual platform version. In the
hidden platform task, hydrophobic rodents must learn to find
a platform submerged below the surface of opaque water in
a pool by learning its location relative to numerous distal
visual cues on the walls of the room containing the pool.
This task is hippocampus-dependent; rodents with bilateral
hippocampus lesions are impaired in their ability to learn
the hidden platform’s location relative to the visual cues, as
compared to sham-lesioned controls. In the visual platform
task, a single visual cue at the location of the submerged
platform, like a flag on the platform emerging out of the water’s
surface, marks the location. This second water maze task is
not hippocampus-dependent; although rodents with bilateral
hippocampus lesions are slower than sham-lesioned animals to
learn the task initially, by the end of standard training periods
their performance is statistically identical. These were exactly
the pattern of results Morris (1989) obtained with AP5-infused
rats.
Intraventricular AP5 infusion also produced motor deficits in
the rats, but a careful subsequent experiment suggested that these
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deficits were independent of water maze performance. Morris
(1989) fifth experiment showed that the dosages of AP5 used in
the memory experiments were sufficient to block hippocampus
LTP in vivo without interrupting normal synaptic transmission.
Nevertheless, selective pharmacological NMDAR antagonists
like AP5 inevitably disrupt synaptic function in subtle ways,
potentially interfering with activity in hippocampus circuitry. As
Silva et al. (1992b, p. 201) put this concern, perhaps the failure
of learning Morris had painstakingly demonstrated ‘‘results not
from the deficit in LTP, but simply from some other incorrect
operation of hippocampus circuits that lack NMDA receptor
function’’. Obviously, a selective NMDAR antagonist like AP5
could not unravel that potential confound.
Taken together, the predicted general applicability of
Capecchi’s gene targeting techniques to mammalian nervous
tissue, and the experimental demand to block LTP without
disrupting other aspects of synaptic function in order to
test the alluring LTP → (rodent spatial) learning and
memory hypothesis, constituted the motivating problem for
the application of gene targeting techniques in mammalian
behavioral neuroscience. Other possible solutions to the second
feature of this motivating problem seemed reasonable to pursue.
One might try to develop more specific pharmacological
agents, along with more precise means of their delivery
to specific neuronal targets in vivo. But this strategy was
known to face limits. Even the most selective receptor
agonists and antagonists inevitably affect synaptic function;
receptor activation is the first (post-synaptic) step of that
complex process. Drugs can leak from injection sites into
surrounding tissue, particularly in behaving animals, and
especially if larger doses are required to elicit desired behavioral
effects. Even the most specific drug typically has ‘‘off-target’’
effects. A more promising strategy would seem to be to
manipulate individual proteins more directly, in specific intra-
or interneuronal molecular pathways underlying quite specific
physiological processes. Capecchi’s gene targeting procedure
seemed ideal for this task. By ‘‘knocking out’’ the specific
gene coding for some judiciously chosen protein product,
one could abolish that protein’s specific contribution to the
phenomena of interest—LTP, rodent spatial learning and
memory, whatever—hopefully without disrupting other aspects
of synaptic function, due to the vastly increased specificity of
the molecular intervention compared to the best interventions
pharmacology could offer. But an immediate question loomed:
which neuronal genes/proteins to target, to test experimentally
the enticing LTP → (rodent spatial) learning and memory
hypothesis?
Like most motivating problems which generate revolutionary
tool development in neuroscience, this one was multi-faceted:
it was a combination of multiple technical problems with a
daunting interactive dynamic.4 Beyond the looming question
4We will see this same feature of ‘‘motivating problem’’ illustrated in our
second case study in the next section. However, it is an open and interesting
metascientific question whether most tool development in neuroscience,
revolutionary or otherwise, is guided by similarly structured motivating
problems. Perhaps in some tool development histories all applications follow
just mentioned lay others. Was Capecchi’s speculation correct,
that his gene targeting technique could work for any cloned
gene of interest? In particular, could it work for a gene
in neurons in vivo? Neurons are relatively delicate cells,
susceptible to cell death in a variety of ways. The gene
target chosen had to code for a protein significant enough
in neuronal signaling pathways to block LTP if eliminated,
and have downstream consequences all the way to behavior
if it was to provide evidence for the LTP → (rodent spatial)
learning and memory hypothesis. These effects had to follow
from the elimination of a single gene and its subsequent
protein product. Yet this disruption had also to be specific
enough not to disrupt other aspects of synaptic function
in excitatory forebrain neurons. Experimenters would have
to verify that the targeted gene’s transcription and protein
production truly was eliminated. The targeted gene could
not interfere with normal development, from the embryonic
stem cell stage when the mutation is engineered, up through
the adult life stage when the behavioral tests would be
administered. Brain development in the mutants had to be
normal, from functioning excitatory synapses all the way up
to gross anatomy of hippocampus circuitry. The behaving
mutants had to possess normal vision, motor capacities, and
motivation to solve the behavioral tasks, so the specific
mutation had to leave all those phenomena intact. And perhaps
most challenging: could all this be accomplished, in one fell
swoop?
Notice that the centrality of this first metascientific concept
of motivating problem for a new tool’s development introduces
distinctively un-Kuhnian aspects to the subsequent account of
neuroscience revolutions. First, experimental tools are just one
component of Kuhn’s multi-component concept of a paradigm;
my claim here is that this one component is central to actual
neuroscience revolutions. But notice that a new tool’s motivating
problem is even more specific: on a specific tool developed for
a specific experimental purpose. Second, a revolutionary new
tool’s motivating problem is not a Kuhnian anomaly. In the
case at hand all serious practitioners in the field recognized the
limits of the best existing pharmacological tool (AP5) put to use
to achieve the overarching experimental goal of testing directly
the LTP → (rodent spatial) learning and memory hypothesis.
It was widely accepted that the existing tools failed to achieve
this specific experimental end; further applications of the existing
tools were not expected to succeed beyond what Morris (1989)
had accomplished. Even the most methodologically conservative
experimentalists recognized the need to develop some new
tool—at a minimum, some new pharmaceutical compound other
than a post-synaptic receptor agonist or antagonist, and a more
specific way to deliver it in vivo. This is not to say that no further
experimental work with compounds like AP5 would be done. It
still had numerous experimental uses. But its use alone could
the tool’s invention. A broader metascientific study of tool development
must address this potential alternate dynamic; suffice it to say that the two
cases of revolutionary tool development discussed in this article answered
to a recognized motivating problem. I thank an anonymous reviewer for
mentioning this alternative account.
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not further confirm the hypothesized LTP → (rodent spatial)
learning and memory causal connection; and no one was puzzled
about why.5
The combination of features of a potentially revolutionary
new tool’s motivating problem illustrated in this case study
also explains why its initially successful hook experiments are
so surprising to the research community. Even scientists ‘‘in
the know’’ about early attempts to develop the new tool assign
a low probability to these experiments succeeding. Due to the
subsequent reaction to these experiments’ publication, not to
mention the number of citations which follow quickly and
sustain, there is usually not much controversy over which
experiments constitute a revolutionary new tool’s initial ‘‘hooks.’’
They are the first published results using the tool: (1) typically in
a top journal in the field; which (2) specifically apply the tool to
the targeted population of experimental interest; and (3) address
a phenomenon in the targeted field of inquiry. For gene targeting
techniques in mammalian behavioral neuroscience, these initial
hook experiments were published in Silva et al. (1992a,b)
and Grant et al. (1992). All three articles were published in
Science (condition 1), all targeted a specific gene/protein in mice
(condition 2), and all tested effects of the genetic intervention
on LTP in hippocampus slices using then-state-of-the-art
electrophysiological techniques and measures, and long-term
learning and memory in water maze and other hippocampus-
dependent (declarative, explicit) tasks (condition 3).
Alcino Silva, working in Susumu Tonegawa’s lab, used
Capecchi’s gene targeting technique to knock out the gene for
the α-isoform of the calcium-calmodulin-dependent kinase II
α-CaMKII). Some features of this protein were then known. It
is highly enriched in the post-synaptic densities of mammalian
forebrain excitatory neurons, including hippocampus and
neocortex. It plays a role in NMDAR-dependent LTP. It is
activated by calmodulin loaded with intracellular Ca++, whose
influx into the post-synaptic cell is through activated NMDARs.
Activated α–CaMKII phosphorylates numerous other post-
synaptic proteins, thereby activating them, and itself remains
activated via autophosphorylation after Ca++ influx ceases. In
these ways α-CaMKII already met some key requirements of a
computational model of a molecular mechanism to strengthen
synapses developed a few years earlier by Lisman (1985) and
Lisman and Goldring (1988). Lisman’s model itself was a more
specific version of Hebb (1949) famous ‘‘fire together-wire
together’’ speculation.
Silva et al. (1992b) constructed the plasmid that disrupted
the α-CaMKII sequence, transfected the plasmid into mice
embryonic stem cells, injected the stem cells into blastocytes,
5An anonymous reviewer drew a potentially intriguing distinction between
tool development, along the un-Kuhnian lines suggested here, and concept
development in neurobiology, which might better match Kuhn’s account of
paradigm shift and anomalies. I admit that my focus on the neurobiology
of memory in these case studies might be occluding the discussion from
conceptual revolutions, because plastic synapses have dominated theorizing
and experimental research onmemory and the brain for more than a century.
This point is worth serious consideration, but would take this article beyond
its intended scope of showing how central experimental tool development has
been in neurobiological revolutions.
inserted the blastocytes into pseudo-pregnant females, bred
the resulting chimeric males with wild-type females, and
after multiple crosses confirmed the expected Mendelian
ratios (wild-type homozygous, wild type-mutation heterozygous,
mutation homozygous) for a non-lethal mutation. Homozygous
α-CaMKII mutants completely lacked α-CaMKII messenger
RNA (mRNA) and protein in forebrain tissue, or any truncated
form of them, but showed normal mRNA and forebrain
protein levels for the closely related β-CaMKII isoform. Coronal
sections through hippocampus revealed no gross anatomical
abnormalities in cell types, distributions, or axonal pathways.
Aside from ‘‘increased jumpiness’’ or ‘‘nervousness’’ when
handled by humans, mutant mice behaved normally. The
mutation had no effect on long-term survival under standard
laboratory housing. In light of all these preserved features, wild-
type littermates could be used as controls for experimental
mutant mice, for both slice-physiological and behavioral studies.
Electrophysiological studies using hippocampus slices found
no differences between α-CaMKII mutants and controls in
synaptic currents, in either NMDA or non-NMDA components.
Measures included peak size, time course, and ratio of NMDA
to non-NMDA components. Nor were there any differences in
the dependency of NMDAR channel conductance on neuronal
membrane voltage potentials (Silva et al., 1992b, Figures 3, 4).
NMDAR function in α-CaMKII mutant mice slices was normal.
So this initial hook experiment delivered successfully on one key
desideratum of the motivating problem: the targeted mutation
did not disrupt synaptic function. The key confound plaguing the
most careful and specific pharmacological studies of the LTP→
(rodent spatial) learning and memory connection was resolved.
But that part of the motivating problem was, relatively speaking,
the easy part. Could this single targeted gene mutation produce
the needed physiological and behavioral effects?
Silva et al. (1992b) next investigated the second desideratum,
impaired LTP in hippocampus slices, using both field potential
recordings to survey populations of hippocampus neurons
and more sensitive whole-cell recordings. They demonstrated
deficient LTP in mutant hippocampus slices. Slices from
littermate controls showed normal tetanus-driven LTP for all
time periods measured (up to 1 h after tetanus). Aside from a
brief post-tetanus stimulus potentiation (about 1 min), synaptic
strength in mutant slices was unchanged from baseline levels,
and remained so even after a second tetanus with increased
pulse trains was delivered. In whole-cell recordings most all
hippocampus neurons in control slices exhibited normal LTP,
while only a small fraction of α-CaMKII neurons did. Quantal
analysis did reveal that the LTP induced in the small fraction of
α-CaMKII neurons displaying it was normal (Silva et al., 1992b,
Figures 6–8, and Table 1). So this single gene/protein mutation
reliably diminished LTP in hippocampus neurons.
Silva et al. (1992a) investigated the third desideratum on the
motivating problem, behavior in vivo in rodent hippocampus-
and non-hippocampus-dependent learning and memory tasks.
α-CaMKII mutants were slower to learn the non-hippocampus-
dependent visible platform version of the Morris water maze
task initially, but over a standard 2-day, 12-trial training period
quickly matched control performance. Interestingly, this pattern
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mimicked both hippocampus-lesioned and AP5-administred
animals (discussed above). On the hippocampus-dependent
hidden-platform version, α-CaMKII mutants never learned to
locate and mount the platform as quickly as controls, over
either a standard 3-day or 5-day training period. In probe trials
after training, where the platform was removed, mutants spent
significantly less time in the maze quadrant where the platform
had been located during training, and crossed the platform’s
training location significantly fewer times, than did littermate
controls. They also crossed the training location of the maze
significantly fewer times compared to controls in a small number
of random-platform trials interspersed during training, where
the hidden platform was changed to a new location (Silva et al.,
1992a, Figures 1–4). However, α-CaMKII mutants performed
normally compared to controls on a water-filled plus maze task,
which requires animals to use a single distal visual cue to learn
which arm holds the hidden platform, (in contrast with the
spatial relations between platform location and numerous distal
visual cues, required on the hidden-platform Morris water maze
task; Silva et al., 1992a, Figure 5). Thus the mutants’ failures to
learn the hidden-platform Morris water maze task were not due
to an inability to see the distal cues, or to learn an association
between escape and the distal visual environment. Interestingly,
α-CaMKII mutants also demonstrated other subtle behaviors
similar to mice with hippocampus lesions (in addition to the
‘‘jumpiness’’ to human contact noted above), such as increased
exploration and activity in open fields and enclosed Y-mazes.
Silva et al.’s (1992a) own words about their results illuminate
the dual metascientific notions of motivating problem and
initial hook experiments developed here. They assert that
their work ‘‘strengthens considerably the contention that the
synaptic changes exhibited in LTP are the basis for spatial
memory.’’ Perhaps more surprisingly, and for the first time,
it ‘‘demonstrates that a mutation in a known gene is linked
to a specific mammalian learning deficit, and indicates that
single genetic changes can have a selective but drastic impact
on learning and memory.’’ Finally, and with an eye to the
future use of the tool they had demonstrated as applicable to
mammalian behavioral neuroscience, they predict that ‘‘other
similarly constructed mice with mutations in judiciously chosen
genes will be useful for studying mammalian behavior’’ (Silva
et al., 1992a, p. 210).
Learning and memory neurobiologists did not have to wait
long for this prediction to be met. Five months later another
set of initial hook experiments was published. Grant et al.
(1992) working in Eric Kandel’s lab, engineered mutations in
mice to the genes for each of the four nonreceptor tyrosine
kinases, src, fyn, yes, and abl. The motivating problem for
Grant et al. (1992) work was that for Silva and collaborators:
the widely accepted limits of pharmacological agents and
their method of application adequately to test the LTP →
(rodent spatial) learning and memory connection. Tyrosine
kinase inhibitors had been shown to block the induction of
LTP without affecting normal synaptic transmission, but the
existing drugs lacked the specificity necessary to identify the
specific tyrosine kinases involved. Grant et al. (1992) used
Capecchi’s gene targeting technique to knock out each of these
four nonreceptor tyrosine kinases in different mouse mutants.
Synaptic transmission in hippocampus slices encompassing
CA3-to-CA1 circuitry from each of the four mutants was normal
compared with littermate controls, including maximum field
EPSPs and paired-pulse facilitation (Grant et al., 1992, Figure
2). LTP in CA1 neurons was normal in src, yes, and abl
mutants, but impaired in fyn mutants, in both field EPSP and
population spike. Strong intensity tetanus stimulation produced
a reduced form of LTP in fyn mutants, and was blocked
by applications of AP5. Whole-cell patch clamp recordings
indicated that the NMDA component of excitatory currents in
the fynmutants was normal; synaptic depolarization of the post-
synaptic cells produced by the input was adequate to activate
NMDAR function (Grant et al., 1992, Figures 4, 5). Behaviorally,
just like the α-CaMKII mutants (and hippocampus-lesioned
and AP5-administered rodents), fyn mutants were initially
slower to learn the visual-platform version of the Morris water
maze task, but eventually matched control performance during
standard training durations. However, they never matched
control performance on the hidden-platform version, either
during standard (7-day) training, or on probe trials after training
on either time in target quadrant or number of target crossings
(Grant et al., 1992, Figure 6). LTP and behavior in hippocampus-
dependent spatial learning both were normal in src, yes, and
abl mutants. However, fyn mutants displayed a developmental
deficit, in the arrangements of hippocampus dentate gyrus
granule neurons and their target CA3 pyramidal neurons (Grant
et al., 1992, Figure 7).
These authors were likewise enthusiastic about the general
applicability of this new gene targeting tool, now demonstrably
feasible for mammalian behavioral neuroscience by work from
two labs: ‘‘In addition to their role in the study of behavior
and learning, targeted disruption of genes provides a powerful
tool for examining the role of specific proteins in the function
of the brain’’ (Grant et al., 1992, p. 1908). And these initial
hook experiments stuck. In October 1992, 4 months after
the Silva et al. (1992a,b) articles had been published and
2 months before the Grant et al. (1992) article appeared,
Morris himself, with Mary Kennedy, published a review, ‘‘The
Pierian Spring’’ in Current Biology, with the subtitle ‘‘mutant
mice engineered to lack an enzyme critical for long-term
synaptic plasticity are deficient in spatial learning’’ (Morris and
Kennedy, 1992, p. 511). They outlined the genetic engineering
procedures used, and the electrophysiological and behavioral
investigations employed, for non-specialists, and closed with a
section on ‘‘Implications and potential.’’ The α-CaMKII knock-
out was ‘‘an ingenious piece of molecular engineering’’; the
LTP and behavioral deficits ‘‘were by no means a foregone
conclusion’’; the work ‘‘should be recognized as the considerable
achievement it truly represents.’’ The findings ‘‘vindicate and
extend earlier results’’ (namely, Morris’s own!) (Morris and
Kennedy, 1992, p. 513). The authors note that this work
was not without its own problems. The learning capacities in
mutants might have been underestimated. The subtlety of the
effects of eliminating so significant a post-synaptic protein in
forebrain excitatory neurons might reflect compensatory effects
of other CaMKII isoforms. α-CaMKII was eliminated completely
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from the mutants’ brains, including from all regions and pre-
synaptically, and so these specific mutants could not be used
to address the then-still raging controversy over whether LTP
was mediated pre-synaptically, post-synaptically, or both. α-
CaMKII is also prominent in neocortical excitatory neurons,
and consolidation and long-term storage of spatial memories
probably occurs there, in addition to hippocampus; that phase
of memory induction may too depend on α-CaMKII activation,
which would also be blocked in the mutants. Despite these
problems, however, these first hook experiments were ‘‘an
auspicious beginning and likely to fund a small industrial
revolution.’’ Rather than treading lightly with this new tool,
neuroscientists interested in the brain mechanisms of learning
and memory ‘‘should, as Pope went on to write, ‘‘Drink deep,
or taste not the Pierian Spring’’6 Morris and Kennedy, (1992,
p. 514).
Neuroscientists, and not just those working on learning
and memory, certainly heeded Morris and Kennedy (1992)
recommendation. Gene targeting quickly became standard
practice across neurobiology, which greatly expanded the then-
nascent search for molecular mechanisms of ‘‘higher’’ functions.
This new experimental tool brought molecular neuroscience to
the prominence in the discipline it maintains to the present day.
But the initial hook experiments which expose a new tool to
the purview of professional scientists are just one component
of genuinely revolutionary tool development. A second kind
of hook experiment garners the tool even wider appeal and
application. Identifying these ‘‘second-phase’’ hook experiments
for any given revolutionary tool is more controversial, as
there are often a number of viable candidates. For gene
targeting techniques in behavioral neuroscience, however, the
general shape of these second-phase hook experiments was
anticipated by both Silva et al. (1992a) and Grant et al. (1992):
engineered genetic mutations more specific than whole-gene
knock-outs. Silva et al. (1992a, p. 210) write: ‘‘Perhaps even
more useful would be . . . mice with mutations directed to
specific regions of the brain. Construction of such mutant
mice may be feasible’’. Grant et al. (1992, p. 1908): ‘‘To
strengthen the links between Fyn, hippocampus LTP, an
spatial learning, it will also be necessary to specifically
manipulate the expression of mutant forms of Fyn, restricted
only to the hippocampus’’. The continued development and
use of gene targeting in mammalian behavioral neuroscience
quickly exceeded both groups’ expectations. Not only did the
regional specificity both envisioned follow quickly, but so did
temporal spexcificity, the capacity to express engineered gene
mutations only during specific developmental phases, e.g., in
adult rodents, and even at specific times during behavioral
protocols.
A new molecular target for learning and memory studies
emerged first. Günther Schütz’s developmental biology lab
6Morris and Kennedy (1992) drew their title from this line of Alexander
Pope’s early-18th century poem, ‘‘An Essay on Criticism.’’ The line of the
couplet that precedes this quoted line, also quoted by Morris and Kennedy
(1992) at the beginning of the review, is perhaps the most famous line from
the poem: ‘‘A little learning is a dangerous thing’’.
developed a homozygous knock-out mouse deleting the gene
for the α- and δ-isoforms of cAMP-response element-binding
protein (CREB). CREB is a transcriptional enhancer prominent
in many tissues. Earlier work with flies, including gene targeting
work, and with the sea slug Aplysia californica, suggested that
CREB, when activated via phosphorylation, enhanced expression
and synthesis of a variety of genes and proteins important for
LTP (or for ‘‘long-term facilitation,’’ as the process is called in
invertebrates) and for invertebrate forms of associative learning.
Working with Schütz’s CREB mutants in Silva’s lab at Cold
Spring Harbor, Bourtchuladze et al. (1994) showed they were
deficient in long-term memory tasks (24-h delay), but intact in
learning and short-term memory (30–60 min delay) on these
same tasks. Behaviors included both hippocampus-dependent
(single-training trial aversive contextual fear conditioning, where
the animal is conditioned with a foot shock after initial exposure
to a new environment, and the hidden-platform version of
the Morris water maze) and non-hippocampus-dependent tasks
(single-training trial cued Pavlovian aversive conditioning to
an auditory tone). These results suggested that CREB plays a
key role in the consolidation of memory from short-term to
long-term form. Hippocampus slice-physiology work proved
consistent with this interpretation of the behavioral results. LTP
inmutant slices was smaller than littermate controls and declined
to baseline by 90 min (Bourtchuladze et al., 1994).
CREB mutants immediately became the target of extensive
behavioral neuroscience investigations, and the same pattern
of results emerged for an large variety of rodent memory
tasks: intact short-term performance but impaired long-term
performance on the same tasks. This pattern held both for
standard memory consolidation and for reconsolidation after
stimulus re-presentation. The importance that CREB mutants
played for learning and memory research over the next few
years after Bourtchuladze et al.’s (1994) second-phase gene
targeting hook experiments is nicely summarized by Dudai
(2002, p. 65) in his introductory sourcebook for memory
research:
CREB is one of the most commonly used acronyms in neurobiology
these days, and also one of the few words in the jargon of molecular
biology that even experimental psychologists and computational
neuroscientists might have encountered. And if they didn’t, they
should. Because the more we advance our knowledge in molecular
biology the more we realize that CREB plays a pivotal role in the
response of neurons to external stimuli.
Dudai’s remarks demonstrate one crucial feature of second-
phase hook experiments for genuinely revolutionary tools:
widespread dissemination of the tool and its results to a
wider public, beyond the specialists working in the field that
developed it.7
Neuroscientists were also soon attracted to a different
kind of gene engineering technique, the transgenic approach.
This approach involves inserting an extra copy or copies
of a cloned gene into the DNA of mammal embryonic
stem cells, often attached to a promoter region which limits
7We will also see this point illustrated in the second case study of
neuroscience revolution in the next section.
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expression to specific neurons. Every cell in the mutants’
bodies contains the extra transgene copy or copies; but
transgene transcription (and subsequent protein synthesis)
only occurs in those tissues or specific cells possessing
the promoter molecule in sufficient abundance. An early
influential use of this approach in behavioral neuroscience
was Abel et al. (1997) in Kandel’s lab. They inserted
extra copies of the gene for regulatory subunits of the
cAMP-dependent protein kinase A (PKA) molecule into
mouse embryonic stem cells, with a CaMKII promoter
which limited transgene expression to forebrain regions,
including hippocampus (but excluding significant expression
in amygdala). PKA plays a prominent role in the cAMP-
PKA-CREB intracellular signaling pathway. In mammalian
post-synaptic neurons, increased intracellular cAMP (driven
by activation of dopaminergic modulatory neurons) binds
to regulatory submits of PKA molecules. This binding frees
catalytic PKA subunits to translocate to the neuron’s nucleus
and phosphorylate CREB molecules. Phosphorylated CREB in
turn drives gene expression and synthesis for both regulatory
and effector proteins which restructure active synapses, leading
to increased EPSPs to subsequent glutamate pre-synaptic
release. In Abel et al. (1997) R transgene mutants, the extra
R PKA (regulatory) subunits available in neurons in which
the transgene is expressed quickly bind up PKA catalytic
subunits freed by increased cAMP, blocking that early step
in the cAMP-PKA-CREB pathway. At the time that these
second-phase gene targeting hook experiments were carried
out, CREB’s role in LTP and memory consolidation had
already been established, with Bourtchuladze et al.’s (1994)
CREB− mutants (see above). But CREB is phosphorylated
through numerous intracellular signaling pathways, and the
CREB knock-out mice couldn’t distinguish between which of
these pathways was crucial for its role in late-phase LTP
and memory consolidation. Attempts to knock out the PKA
gene using Capecchi-style gene targeting techniques had been
inconclusive.
Abel et al.’s (1997) founder mutant mice bred successfully
and transmitted the transgene to offspring. The promoter
limited significant transgene expression to forebrain areas,
including all regions of the hippocampus, but hippocampus
gross anatomy was otherwise unaffected. Hippocampus
PKA activity was reduced in R transgenic mice, but basal
synaptic transmission, paired-pulse facilitation, and post-
tetanus potentiation to one- or two-train tetanus stimuli
were all unaffected in mutant hippocampus Schaffer
collateral (CA3→CA1) pathways. However, late-phase
(L-) LTP was reduced significantly to four-train stimuli
in mutant slices for all time periods tested (starting at
about 40 min and measured up to 180 min post-tetanus).
Behaviorally, while escape latency during training on the
hidden-platform version of the Morris water maze task
in R transgenic mutants did not differ from littermate
control performance, mutants were deficient in both time-
in-target quadrant and number of target crosses in probe
trails administered after training (Abel et al., 1997, Figure
5). More importantly, R transgenic mutants were intact
on short-term (1-h delay) contextual fear conditioning,
significantly impaired on the long-term (24-h delay) version,
but unimpaired on both short-term and long-term versions of
tone-foot shock (Pavlovian) conditioning compared to control
mice. The latter task is amygdala-dependent, where the R
transgene was not expressed significantly due to the CaMKII
promoter.
Two more recent second-phase hook experiments bring us
up to date on the development of gene targeting targeting
techniques in behavioral neuroscience. The first used conditional
gene knock-outs, which temporarily and reversibly repress a
targeted gene’s expression and protein synthesis. An important
hook experiment for this development was Kida et al. (2002),
who fused a CREB α-isoform repressor (IR, with an alanine
residue substituted for the serine residue at positon 133) to a
ligand-binding domain of a human estrogen receptor mutated
to become activated by the drug tamoxifen (TAM). Kida et al.
(2002) derived transgenic mice expressing this CREBIR mutation
under the control of an α-CaMKII promoter to render it active
only in excitatory forebrain neurons. The CREBIR isoform
protein competes with phosphorylated CREB for binding sites
on target regulatory and effector genes, and represses expression
at those sites, but only for the duration of systematic TAM
administration. At all other times the CREBIR transgene is silent
with no effect on CREB activity (including throughout brain
development). CREBIR activation did not disrupt short-term
memory (2-h delay) for (hippocampus-dependent) contextual
fear conditioning, but disrupted its consolidation into long-
term form (24-h delay). CREBIR activation also impaired the
stability of reactivated fear conditioned memories in mutants,
Mice were returned to the context paired with the foot shock
24 h after initial training (the ‘‘reactivation’’ phase) and were
then retested in the context 24 h later. Transgenics whose
CREBIR repressor isoform was activated by TAM during
memory reactivation froze significantly less to the context at
retest than did the three control groups: wild-type littermate
controls, transgenics whose CREBIR repressor was not activated,
and transgenics whose CREBIR was reactivated but whose
context-fear memories were not reactivated by context re-
presentation. The results from this second-phase gene targeting
hook experiment with a temporally conditional knock-out
mutation provided a crucial piece of evidence that CREB
is part of the molecular mechanism for both consolidation
and reconsolidation of hippocampus-dependent (‘‘declarative’’)
memory.
The use of engineered virus vectors to deliver transgenes
via the usual process of the virus replication cycle also enabled
scientists to bypass possible developmental abnormalities which
result from insertions in embryonic stem cells, and to insert genes
of interest directly into the neurons of adult mammals. Delivery
of virus vectors via microinjection further limited infection, and
hence transgene transfer, to specific neural regions. An early
application of this technique to behavioral neuroscience was
Josselyn et al.’s (2001) work, in Michael Davis’s lab. Rodents
show increased L-LTP, and increased long-term learning, in
tasks requiring multiple training sessions when training sessions
are spaced, with non-training intervals in between, rather than
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when massed into a single multiple-exposure session. Josselyn
et al. (2001) showed that rats who received infusion of a
transcription enhancer isoform of the CREB gene, with the
virus vector microinjected bilaterally into the basolateral nucleus
complex of the amygdala, showed significantly enhanced long-
term memory with massed training on a fear-potentiated startle
paradigm involving four light-shock pairings. No control groups
showed any increase in long-term memory performance to
massed training: rats microinjected with a control substance,
rats microinjected with a mutated inactive form of the CREB
gene, rats microinjected with a Lac-Z gene with no learning
and memory effects, rats whose microinjections had missed or
whose infections had extended beyond the amygdala basolateral
nucleus, and rats microinjected with the CREB gene directly
into the caudate nucleus. There were no differences across
groups in immediate reactions to shocks, explicitly unpaired
training failed to produce long-term memory in the CREB-
boosted rats, and increased long-term memory was retained in
CREB-boosted rates 14 days after massed training. As Josselyn
et al. (2001, p. 2410) remark, their results were first to show that
‘‘overexpression of CREB in a specific mammalian brain region
at a specific time enhances LTM [long-term memory]’’. These
types of experiments, labeled ‘‘mimicry’’ by Sweatt (2009) and
‘‘positive manipulations’’ by Silva et al. (2014), provide a kind of
evidence widely recognized as necessary for scientific confidence
that a hypothesized causal connection, e.g., CREB expression in
specific brain regions → enhanced LTM, has genuinely been
established.
The gene targeting revolution across mainstream
neuroscience is now fully accomplished. The technique is
a mainstay of work in cellular, molecular, and behavioral
neuroscience across all phenomena. Any research institutions
of any serious standing now has a core facility to develop
conditional knock-out and transgenic rodents (and other
mammals), not just for neurobiologists, but for all fields of
bio-medical inquiry. The vast increase in our knowledge of
direct cellular and molecular mechanisms for ‘‘higher-level’’
biological phenomena of all types can be traced to the application
of these techniques. To deny this scientific development the
status of a revolution would be simply to misunderstand its
significance in current scientific inquiry. But the actual dynamics
of this revolution, in recent neuroscience as in all other fields,
hinged on the development of this tool, especially the roles of
its motivating problem, and initial and second-phase hook
experiments. These features, rather than anything deemed
crucial on Kuhn’s famous model, were this scientific revolution’s
vanguard.
CASE STUDY #2: OPTOGENETICS AND
DESIGNER RECEPTORS EXCLUSIVELY
ACTIVATED BY DESIGNER DRUGS
(DREADDs)
For a second detailed case study of an actual neuroscientific
revolution, consider optogenetics, an experimental technique in
existence in neuroscience for scarcely one decade (even though
some of its resources have been standard in molecular biology
for three times that long). This is an especially interesting case
of scientific revolution, not only because the science itself is so
intriguing and was initially so implausible, but also because it
is a revolution still in the making. Yet it is difficult to deny
that optogenetics’ impact on neuroscience has already been
revolutionary. Since it was named ‘‘Method of the Year’’ in 2010
by Nature, the number of optogenetics publications searchable
annually has increased from roughly 100 to already close to 900,
through only the first half of 2015 (Deisseroth, 2015). Recent
reviews discuss experimental results in mammalian behavioral
neuroscience ranging from learning and memory, sleep/wake
transition, addiction, motivation, reward, social interactions,
anxiety, and models of neurological disease and trauma.8
Being an ongoing, still potential revolution implies, of course,
that the optogenetics revolution might not come to fruition.
Otchy et al. (2015) report results which challenge an assumption
behind the experimental use of rapid and reversal manipulations
of neural activity like optogenetics, that the observed behavioral
effects reflect the function of the manipulated circuits. This
assumption is problematic because of indirect effects of the
manipulation on independent downstream circuits, which are
difficult to control. So noted. Despite its role in kick-starting
neurobiological revolutions, tool development is just one aspect
of progressing science, revolutionary or otherwise.9
One feature that makes optogenetics appealing as an
experimental tool is the unprecedented control it offers over
the activation (or inhibition) of specific targeted neurons in
living, behaving animals. Various classes of light-responsive
proteins, most prominently the microbial opsins from algae,
serve as membrane-spanning channels for cation (e.g., sodium,
Na+) or anion (e.g., chloride, Cl−) influx, thereby depolarizing
or hyperpolarizing the cell when activated. The DNA coding
for these opsins is removed and engineered to be expressed
effectively in mammalian DNA. It is inserted via a virus vector,
nowadays typically an engineered adeno-associated virus whose
own genetic material has been removed to allow insertion of
the engineered opsin DNA. The virus vector is then micro-
injected directly into specific regions of mammalian brains,
typically mice or rats. Specific neurons infected by the virus
take up the engineered opsin DNA by the usual mechanisms
of the viral replication cycle. They are thus poised to begin
expressing the engineered gene and synthesizing the new protein,
under the control of the promoter region of the engineered gene.
These synthesized opsin proteins embed in the infected neurons’
membranes. They now can be activated by a light stimulus to pass
the specific cation or anion into these neurons, thereby activating
or inactivating them at the experimenters’ command—by
switching on the laser or light-emitting diode (LED) light source
8I will have more specific things to say in defense of optogenetics’
revolutionary nature after I explain the technique, canvass some results, and
apply the notions of motivating problem and hook experiments to these
details.
9See Silva et al. (2014, Chapter 1) for a broader perspective of how Tool
Development experiments fit with other kinds of experiments in science. I
thank an anonymous reviewer for reminding me about this concern, and for
pointing me to the Otchy et al. (2015) article.
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embedded in the animal’s brain. The stimulating light source
is inserted through chronically implanted cannulae cemented
permanently into the animals’ skulls. Activating (or inactivating)
specific neurons can have downstream effects of activating (or
inactivating) entire neuronal circuities. Typically the engineered
DNA for an imaging protein (mCherry, green florescent protein,
yellow fluorescent protein) is also coupled to the engineered
DNA for the opsin protein in the virus vector. All neurons
infected by the virus will also express the imaging protein, and
glow a particular color (red, green, yellow) in brain tissue slices
under standard light microscopy. Experimenters can thus verify
exactly which neurons expressed the opsin protein, and were
activated (or inhibited) by the light stimulus (this is all now
standard procedures for the use of viral vectors in gene targeting,
introduced toward the end of the previous section).
Those are the basics. Further refinements to these techniques
typically depend upon the specific experimental questions
optogenetics is used to address. For example, memory
researchers often insert the opsin transgene against an already-
genetically engineered rodent background that activates the
expressed opsin transgene only in infected neurons that are also
highly activated by the target memory stimulus. Many types of
highly active neurons express c-fos, the protein product of an
immediate early gene, which in turn can drive the production
of an engineered tetracycline-responsive element promoter
protein, which turns on opsin transgene expression only in
infected neurons which are also the most highly active. At all
other times this background tetracycline-transactivator system is
kept silent by doxycycline in the animals’ diets. This trick enables
experimenters later to turn on via the light stimulus all and only
those infected neurons which were most active during memory
formation—the hypothesized cellular engram for the memory
stimulus.
Designer receptors exclusively activated by designer drugs
(DREADDs) technology is a more recent refinement which
dispenses with optogenetics’ inserted light stimulus. Instead of an
engineered microbial opsin gene, the gene for an entire protein
receptor for a designer drug—a compound, such as clozapine-
N-oxide (CNO), which nowhere occurs naturally in biological
tissue—is inserted via the virus vector. These engineered
receptors are metabotropic (coupled to a G-protein), to induce
either bursting (Gq-type protein) or silencing (Gi-type protein)
in infected neurons. The designer drug is then administered
systemically, either through peritoneal injections or diet. It binds
to the engineered receptors in the infected neurons, activates the
attached G-protein complex, and induces bursting or silencing
in those neurons for the extent of the pharmacological activity of
the designer drug.
Neurobiologists are now furiously exploring the relative
advantages and disadvantages of optogenetics vs. DREADDs.
The lack of need for an implanted light source is one
technological advantage of DREADDs. So can be the number
of neurons activated by the drug. Systemic administration of
the designer drug means that all the neurons infected with
and expressing the transgene for the designer receptor will be
affected, no matter where they are located in the brain. In
optogenetics, only those neurons infected, expressed, and in the
range of the stimulating light source are affected. This extent
of the drug’s effect is a two-edged sword, however. It puts
a premium on micro-injection placement of the DREADD-
containing virus and subsequent verification of this placement.
Leakage of the virus into other non-target neurons, and
subsequent expression of the designer receptor in them, can
confound behavioral results. On the other hand, DREADDs’
temporal control is tied to the pharmacokinetics and -dynamics
of the designer drug—its absorption, distribution, metabolism
into inactive metabolites, and excretion. This slow and imprecise
temporal effect contrasts sharply with optogenetics’ temporally
much more tightly controlled on/off light switch. Both
techniques permit anterograde-retrograde interactions, in which
the specific neuronal targets of the axons of the optogenetics-
and DREADD-activated neurons can be identified and in turn
manipulated.
The two metascientific concepts illustrated in the case
of revolutionary gene targeting techniques in neuroscience
are also present in the ongoing optogenetics revolution. The
motivating problem for optogenetics stemmed from the causal-
mechanistic explanatory goals of mainstream neurobiology.
To test hypotheses about the causal role played by specific
neurons to produce behaviors routinely taken as indicators
of particular cognitive functions in mammalian models,
experimenters need the capacity reliably to intervene into
the hypothesized mechanisms in vivo—to activate or inhibit
them in the behaving organism, as directly and as efficiently
as possible. They can then measure the effects of these
experimental interventions on the behaviors of the organism,
in tightly controlled experimental protocols routinely taken
to be indicators of the target phenomenon. This task has
become more difficult in light of continued discoveries of the
sometimes sparse anatomical distributions of the hypothesized
cellular mechanisms. Pharmacological interventions easily can
be confounded by the spread of the drug to nearby non-
target neurons; nature doesn’t always cooperate to clump target
neurons together into discrete cortical columns or microcolumns
to make stimulation by microelectrodes feasible. The intriguing
suggestion of using light stimuli to activate or inhibit target
neurons was already on offer (Crick, 1999). The ‘‘obvious’’
solution was to develop some way to induce the distributed
specific target neurons themselves to synthesize light-sensitive
ion channels. But that solution explodes quickly. For speed of
activation or inhibition the expressed ion channels should be
ionotropic, which simply open direct channels for a specific
cation or anion influx or efflux. Engineered gene expression
and protein synthesis would have to be at levels both safe
and in sufficient numbers to have enduring effects on neuron
membrane potentials. The activating light stimulus had to be
deliverable to induced neurons safely, often deep in the brain,
yet with sufficient strength to induce sufficient activity in enough
of the target neurons to affect circuit activity. And all of this
had to be implemented in vivo. But if successful, neurobiology
would then have a great new experimental interventionist tool
to explore causal-mechanistic hypotheses relating activity in
specific neurons to behaviors—including behaviors routinely
taken to indicate the occurrence of particular cognitive functions.
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This was optogenetics’ motivating problem. Like most
motivating problems which generate revolutionary tool
development in neuroscience, including the example of gene
targeting techniques discussed above, this was a composite of
many technical problems with a daunting interactive dynamic.10
Deisseroth (2015), in whose lab optogenetics in its current form
was first successfully developed, summarizes this situation nicely.
The three core features of the optogenetics technique include
the engineered microbial opsin genes and proteins; general
methods for targeting opsin expression to well-defined neurons;
and methods for guiding light stimuli to brain regions, often
deep below the cortical surface, while the organism carries out
the behaviors of interest. Each component problem individually
faced serious difficulties; but together they constituted ‘‘a
biological three body problem in which it was hard to resolve
(or, even more importantly, to motivate attempts to resolve)
any one of the three challenges without first addressing the
other components’’ Deisseroth (2015, p. 1214). Ion currents
through microbial rhodopsin proteins were predicted to be
very small; hence high gene expression and light-intensity levels
seemed necessary. These levels of expression and synthesis had
to be sustainable in neurons, biological cells well known to be
detrimentally sensitive to membrane protein overexpression,
and to side effects of heat and light. All this plus the specificity
of expression had to be achieved while minimizing cell toxicity,
in order to be applicable in vivo. Furthermore, attempts were
already underway to use engineered metazoan rhodopsin genes
and channel proteins (which mediate photon transduction in
vertebrate retina), which reduced initial enthusiasm for trying to
solve these technical problems using a family of genes so foreign
to the mammalian genone.
Again, this combination of features of the motivating
problem for a revolutionary tool development illustrates why
the successful initial hook experiments were so surprising.
Even scientists ‘‘in the know’’ about early attempts to develop
optogenetics in the form it took assigned a low probability
to these experiments succeeding. To repeat from above, thee
experiments are the first published experiments using the
technique: (1) usually in a top journal in the field; (2) applying
it to the targeted experimental population of research interest;
while (3) addressing a phenomenon in the target field of inquiry.
For optogenetics, this was the Adamantidis et al. (2007) study
from the Deisseroth lab. Condition (1) was met: the article was
published in Letters to Nature.
Adamantidis et al. (2007) engineered a lentivirus using
the promoter region of the mouse (condition 2) prepro-
hypocretin gene (Hcrt). This limited expression of the engineered
microbial opsin gene, channelrhodopsin2 (ChR2) to hypocretin-
(also known as orexin-) producing cells. They micro-injected
this virus vector into mouse lateral hypothalamus. Expression
persisted and was highly specific to Hcrt-producing lateral
10Note that, intuitively, the motivating problems for each of the other two
instances of revolutionary tool development in contemporary neuroscience I
mentioned above-high-output electrodes for single-cell recording in vivo and
functional brain imaging -also share this feature. One might be starting to
sense a pattern . . .
hypothalamic neurons. Electrophysiological studies with tissue
slices in vitro showed that ChR2-expressing Hcrt neurons
reliably responded to light stimuli with volleys of action
potentials (Adamantidis et al., 2007, Figure 1). Optogenetic
photostimulation of ChR2-expressing lateral hypothalamus Hcrt
mice also activated infected neurons in vivo, as measured by
increased c-fos expression specifically in these neurons. And
optogenetic photostimulation to lateral hypothalamus in vivo
in ChR2-Hcrt mice outfitted for chronic electroencephalogram
(EEG) and electromyogram (EMG) recordings showed that
direct activation of these neurons significantly decreased latency
to wakeful state, from both slow wave sleep (SWS) and rapid
eye movement (REM) sleep (condition 3), as compared to both
baseline (non-photostimulated) latency in these same mice and
photostimulation in control mice (who received the virus vector
injections minus the ChR2 transgene; Adamantidis et al., 2007,
Figure 3). Effects of photostimulation appeared limited to sleep-
wake transitions since duration of waking EEG and EMG events
did not differ significantly across groups. These effects were
dependent upon frequency of the photostimulation, however,
as 15 ms light pulses delivered at 1 Hz did not elicit them,
while all frequencies greater than 5 Hz did. And the mechanism
of these photostimlation-induced effects influenced the sleep-
wake circuitry by affecting Hcrt release in the infected neurons.
Administration of a single dose of an Hcrt receptor (type 1)
antagonist (SB334867) blocked this photostimulation effect on
sleep-wake transition latency, from both SW and REM sleep
(Adamantidis et al., 2007, Figure 4).
As Deisseroth himself notes, the Adamantidis et al. (2007)
study was the first experiment to demonstrate that
it was possible to selectively target a microbial opsin gene with
high specificity and penetrance to a defined population of neurons
deep in the brain of adult mice . . . to play in a broad range of
spike patterns throughout an optical fiber to these cells, to collect
simultaneous multimodal system readouts during freely moving
behavior, . . . and to demonstrate a causal role for defined activity
patterns in specific brain cells in natural behavior.
—(Deisseroth, 2015, p. 1216)
Subsequent applications of developments in gene targeting,
and opsin genomics and engineering, quickly contributed to
the rapid increase in published optogenetics results over the
subsequent few years.
As we saw in our first case study, the initial hook experiments
which expose a new experimental tool to the purview of a
given field’s research specialists are important; but genuinely
revolutionary tools garner even wider appeal by way of second-
phase hook experiments. As it was for the case of gene targeting
techniques, identifying the key second-phase hook experiments
is more controversial, as there are a number of viable candidates.
In the case of optogenetics, however, arguments for identifying
some specific second-phase hook experiments are aided because
the technique has penetrated into the awareness of the general
(scientifically literate) public. One set of recent optogenetic
experiments in particular stands out: work on reactivating
the cellular engrams of specific memories, and pairing these
reactivations with new memorial information to create false
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memories in rodents. This work came from Tonegawa’s lab.
One behavioral protocol the lab employs is contextual fear
conditioning, a hippocampus-dependent (‘‘declarative’’) rodent
memory task. This is the same behavioral protocol used by Abel
et al. (1997) with their R-subunit PKA mutants, discussed in the
section above. The rodent is placed in a novel context, a cage with
an internal environment it has never encountered previously,
allowed to explore for a short duration (1–2 min), and then is
foot-shocked. Later exposures to that environment elicit freezing,
the characteristic rodent fear response: complete suppression
of all movement except breathing and a stereotypic crouched
posture. Time spent freezing indicates strength of memory for
the context-shock association.
Liu et al. (2012) used a transgenic mouse line in which
an excitatory opsin (ChR2) was expressed only during fear
conditioning to the novel context, in the most active neurons
in the dentate gyrus region of the hippocampus. Expression was
limited by the tetracycline-controlled transcriptional activation
system described above. ChR2 opens a direct channel for
sodium (Na+) influx when photostimulated, to depolarize
infected neurons. Hence only the specific infected dentate gyrus
neurons most active during the context-shock pairing, which
constitute the hypothesized cellular engram for the association,
were reactivated by the photostimulation. Liu et al. (2012)
ingenious experimental design was to reactivate the infected
cells encoding the context-shock association to the first context
while the animal was exploring a second and different novel
context. No actual foot shock was administered in that second
context. However, photostimulated experimental mice later
demonstrated significant freezing to the second, non-shocked,
context.
A follow-up study by Ramirez et al. (2013) in Tonegawa’s
lab also expressed the opsin only in the most active dentate
gyrus neurons, but this time during non-shocked exploration of
the first novel context. They reactivated those specific neurons
by photostimulation when the animals underwent context-
fear (foot shock) conditioning in a second novel context.
The experimental mice demonstrated the fear response when
placed back in the first, neutral context, in which they never
were shocked. These experimenters interpret their results
straightforwardly: ‘‘we created a false memory in mice by
optogenetically manipulating memory engram-bearing cells in
the hippocampus’’ (Ramirez et al., 2013, p. 387).11
The Tonegawa lab’s second phase optogenetics hook
experiments not only brought opogenetics to wider scientific
notice, but also attracted huge public interest: ranging from
Smithsonian Magazine to The Guardian to Time Magazine
to neurogadgit.com, to name just a few popular sources that
covered it. Google ‘‘false memory optogenetics’’ to get a quick
feel for the number and range of popular media coverage. Its
scientific revolutionary credentials were perhaps best expressed
in these scientists’ own words. Noting that a case for the
biological mechanism for a specific process involves three
11Philosopher Robins (forthcoming) makes interesting use of these and
other results from the Tonegawa lab to challenge ‘‘constructionist’’ views of
memory, now prevalent in psychology and cognitive neuroscience.
kinds of experimental evidence—‘‘correlation’’ of the parallel
occurrences of hypothesized mechanism and effect; ‘‘blockage’’
of the hypothesizedmechanism, which demonstrates its necessity
for the effect; and ‘‘mimicry’’ of the hypothesized mechanism,
which demonstrates its sufficiency12—Ramirez et al. (2014,
p. 3) note that ‘‘mimicry experiments for memory engram
studies remained a considerable challenge’’. Experimenters
‘‘widely recognized and agreed’’ that mimicry experiments were
essential toward testing the cellular engram hypothesis. But ‘‘the
lack of tools that could precisely label and control selected
neurons involved in a particular memory posed formidable
obstacles to carry out these experiments’’ (Ramirez et al.,
2014, p. 3). Gene targeting techniques using microinjections
of virus vectors for overexpressing genes like CREB and
α-CaMKII in specific neurons prior to training had some
limited successes (e.g., Josselyn et al., 2001, discussed above).
Optogenetics, however, is the first tool which could reliably
‘‘selectively label and activate the memory engram-bearing
cells to induce the predicted behavioral changes caused by
learning,’’ and so reliably provide this final, essential kind of
evidence for direct cell activity → cognitive function causal
hypotheses. Experiments in the neurobiology of learning and
memory could now reliably provide mimicry evidence. And
they did, quickly. Two years after Liu et al.’s (2012) first
results were published a review article appeared in Trends in
Neurosciences, appropriately titled ‘‘The optogenetic revolution
in memory research, ’’ which referenced 100 publications
(Goshen, 2014).
CONCLUDING REMARKS: MOLECULAR
BIOLOGY VS. PHYSICS AS
PARADIGMATIC SCIENCE
Real revolutions in contemporary cellular/molecular/behavioral
neuroscience have little to do with the components and dynamics
of Thomas Kuhn’s famous model, and mostly to do with novel
tool development. The two concepts developed and illustrated
here, motivating problem and hook experiments, are just first
steps toward a metascience of experimental tool development,
the key components of such scientific revolutions. They in no
way exhaust all the interesting metascientific features of tool
development in neurobiology, much less in science generally.
Both components need additional support from other case
studies. But those two alone show ways in which revolutions
in neurobiology depart significantly from Kuhn’s model. It is
also not clear how many other contemporary sciences share
this revolutionary dynamic. But it is illuminating to note that
cellular and molecular biology in general, and biochemistry,
from which much of contemporary mainstream neuroscience
stems, has now outdistanced physics as the most influential
science of our time, in terms of research funding, number of
12These labels are from neurobiologist Sweatt (2009). The attendant concepts
are similar to Silva et al. (2014) notions of ‘‘non-intervention,’’ ‘‘negative
manipulation,’’ and ‘‘positive manipulation’’ experiments, which combine
to make up ‘‘Convergent Three integration,’’ although there are subtle
differences, especially concerning ‘‘mimicry’’ and ‘‘positive manipulation.’’
That discussion is beyond the scope of this essay.
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publications, and number of practicing scientists. Obviously,
numerous social forces drive a great deal of this current influence.
But in light of it, one might legitimately wonder whether the
still-lasting—and as I have argued here, mistaken—influence of
Kuhn’s model of scientific revolution even on these fields is one
lingering relic of mid-20th century philosophy of science, when
physics was assumed to be the paradigmatic science, against
which all others were compared and judged. Perhaps it is now
time for cellular and molecular biology to assume that role?
The recent growing influence of the ‘‘new mechanist’’ approach
in philosophy of science, built most centrally on biology rather
than physics, might be one important, albeit still implicit step in
this direction (Machamer et al., 2000; Craver, 2007; Craver and
Darden, 2014).
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